PaclitaxelAlbuminsSerum AlbuminAntineoplastic Agents, PhytogenicSerum Albumin, BovineAntineoplastic Combined Chemotherapy ProtocolsCarboplatinDrug Administration ScheduleOvarian NeoplasmsTubulin ModulatorsSerum Albumin, Radio-IodinatedInfusions, IntravenousCisplatinDrug Resistance, NeoplasmLung NeoplasmsTaxoidsTreatment OutcomeBreast NeoplasmsDose-Response Relationship, DrugAntineoplastic AgentsDoxorubicinReceptors, AlbuminBridged CompoundsCarcinoma, Non-Small-Cell LungNeutropeniaCell Line, TumorTaxusTechnetium Tc 99m Aggregated AlbuminTubulinPharmaceutical VehiclesEpothilonesDrug SynergismDeoxycytidineDisease-Free SurvivalArea Under CurveMaximum Tolerated DoseP-GlycoproteinSurvival AnalysisAlbuminuriaMice, NudeMicrotubulesPeripheral Nervous System DiseasesEpirubicinFallopian Tube NeoplasmsVinblastineTopotecanCombined Modality TherapyTumor Cells, CulturedNeoplasmsSurvival RateDrug CarriersTime FactorsApoptosisHypoalbuminemiaDrug Delivery SystemsNeoplasm StagingXenograft Model Antitumor AssaysDrug Resistance, Multiple2S Albumins, PlantDrug Screening Assays, AntitumorAntibodies, Monoclonal, HumanizedNanoparticlesCyclophosphamidePeritoneal NeoplasmsPolyethylene GlycolsLeukopeniaIfosfamideNeoplasms, Glandular and EpithelialMicellesHematologic DiseasesThrombocytopeniaFluorouracilBilirubinCarcinomaGranulocyte Colony-Stimulating FactorCell SurvivalChemistry, PharmaceuticalPlatinum CompoundsChemotherapy, AdjuvantAdministration, OralInhibitory Concentration 50Feasibility StudiesEstramustineDrug InteractionsDisease ProgressionPolyglutamic AcidBlood ProteinsAdenocarcinomaRadiation-Sensitizing AgentsPolymersAntibodies, MonoclonalCyclosporinsDrug Hypersensitivity